To explore the gestational dynamics of maternal thyroid hormones and their associations with neonatal birth outcomes.
Key Findings:
Maternal TSH levels increased gradually, while TT3 peaked in mid-pregnancy and FT3/FT4 levels declined continuously.
Correlations between maternal thyroid hormones and neonatal outcomes were noted, with trimester- and sex-specific associations for TT4, TT3, FT3, and FT4 with birth weight, length, and parity.
Dose-response relationships were identified with pregnancy stage and sex-specific patterns.
Positive correlations of thyroid hormone mixtures with neonatal outcomes were noted in early/mid-pregnancy, with significant correlations in late pregnancy.
Interpretation:
The findings highlight the complexity of thyroid hormone dynamics and their associations with neonatal outcomes across different trimesters and infant sexes.
Limitations:
The specific plan and quality control measures for thyroid hormone testing were not documented.
The study population may not be representative of all pregnant women due to specific inclusion and exclusion criteria.
Conclusion:
The study underscores the need for gestational thyroid function monitoring to inform maternal–infant health strategies.
“And when one of these measles cases ends up in a low-immunization community, that's when the ember really has a chance to expand and become a wildfire.”